Complete Filing Data
LeonaBio, Inc. reported Stockholders Equity of $27.79 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean LeonaBio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$105.6M | -$96.9M | -$117.7M | -$95.6M | -$54.9M | -$20.0M | -$5.2M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -$5.0K | $350.0K | $1.6M | -$1.6M | -$421.0K | $33.0K | |
| Research And Development Expense | $17.5M | $70.7M | $93.8M | $61.5M | $42.8M | $13.3M | $3.8M |
| Other Nonoperating Income Expense | $1.2M | $4.0M | $7.6M | $3.2M | $334.0K | -$1.3M | -$466.0K |
| Operating Income Loss | -$102.3M | -$100.9M | -$125.5M | -$104.0M | -$64.0M | -$20.0M | -$5.4M |
| General And Administrative Expense | $16.7M | $26.1M | $33.3M | $32.6M | $21.2M | $6.7M | $1.7M |
| Comprehensive Income Net Of Tax | -$105.6M | -$96.6M | -$116.1M | -$97.2M | -$55.3M | -$19.9M | -$5.2M |
| Other Comprehensive Income Loss Net Of Tax | $33.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.6M | -$7.0M | -$9.1M | -$28.7M | -$26.9M | -$26.3M | -$33.0M | -$29.6M | -$27.8M | -$20.2M | -$24.3M | -$21.0M | -$15.7M | -$14.0M | -$8.9M | -$8.5M | -$2.0M | -$1.8M | -$1.5M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $1.0K | $1.0K | -$5.0K | $41.0K | $99.0K | $212.0K | $261.0K | $90.0K | $927.0K | -$547.0K | -$469.0K | -$1.1M | -$33.0K | $9.0K | -$5.0K | $7.0K | |||
| Research And Development Expense | $2.8M | $3.7M | $4.3M | $17.9M | $22.2M | $21.2M | $27.2M | $21.6M | $21.3M | $17.0M | $14.8M | $14.5M | $10.7M | $12.0M | $7.4M | $5.8M | $1.7M | $592.0K | $1.0M |
| Other Nonoperating Income Expense | $263.0K | $325.0K | $393.0K | $880.0K | $1.2M | $1.4M | $2.1M | $2.0M | $1.8M | $985.0K | $493.0K | $173.0K | $73.0K | $74.0K | $84.0K | -$1.1M | $260.0K | -$560.0K | $5.0K |
| Operating Income Loss | -$6.9M | -$7.3M | -$9.5M | -$29.6M | -$28.0M | -$27.7M | -$35.0M | -$31.6M | -$29.8M | -$24.1M | -$23.6M | -$23.4M | -$17.8M | -$16.6M | -$10.8M | -$7.4M | -$2.3M | -$1.3M | -$1.5M |
| General And Administrative Expense | $4.0M | $3.6M | $5.2M | $7.6M | $5.9M | $6.5M | $7.8M | $10.0M | $8.5M | $7.2M | $8.8M | $8.9M | $7.1M | $4.6M | $3.3M | $1.6M | $575.0K | $675.0K | $509.0K |
| Comprehensive Income Net Of Tax | -$6.6M | -$7.0M | -$9.1M | -$28.7M | -$26.8M | -$26.1M | -$32.7M | -$29.5M | -$26.9M | -$20.7M | -$24.8M | -$22.0M | -$15.7M | -$14.0M | -$8.9M | -$8.4M | -$2.0M | -$1.8M | -$1.5M |
| Other Comprehensive Income Loss Net Of Tax | -$33.0K | $9.0K | -$5.0K | $7.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $27.8M | $44.8M | $130.2M | $235.1M | $321.1M | $274.3M | -$19.7M | -$14.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $69.9M | $49.1M | $91.2M | $96.4M | $110.5M | $60.6M | $2.1M | $3.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $20.8M | -$42.1M | -$5.2M | -$14.2M | $49.9M | $58.6M | -$1.3M | |
| Cash And Cash Equivalents At Carrying Value | $69.3M | $48.4M | $90.6M | $96.0M | $110.5M | $60.6M | $2.1M | |
| Retained Earnings Accumulated Deficit | -$511.8M | -$406.1M | -$309.2M | -$191.5M | -$95.9M | -$41.0M | -$21.1M | |
| Prepaid Expense And Other Assets Current | $1.1M | $3.6M | $5.7M | $6.0M | $4.7M | $6.4M | $97.0K | |
| Liabilities Current | $47.5M | $13.1M | $28.8M | $21.4M | $9.3M | $4.4M | $1.3M | |
| Liabilities And Stockholders Equity | $92.2M | $58.8M | $160.2M | $258.2M | $332.0M | $279.6M | $2.2M | |
| Liabilities | $64.4M | $13.9M | $30.1M | $23.0M | $10.9M | $5.3M | $4.9M | |
| Assets Current | $89.5M | $54.8M | $154.7M | $207.5M | $260.8M | $192.3M | $2.2M | |
| Assets | $92.2M | $58.8M | $160.2M | $258.2M | $332.0M | $279.6M | $2.2M | |
| Additional Paid In Capital Common Stock | $539.5M | $451.0M | $439.7M | $428.6M | $417.4M | $315.3M | $1.4M | |
| Accrued Liabilities Current | $5.0M | $12.4M | $18.3M | $8.6M | $8.4M | $3.1M | $852.0K | |
| Accounts Payable Current | $4.6M | $319.0K | $129.0K | $2.5M | $567.0K | $1.2M | $421.0K | |
| Short Term Investments | $19.1M | $2.8M | $56.8M | $104.4M | $143.2M | $124.1M | ||
| Property Plant And Equipment Net | $1.5M | $2.4M | $3.4M | $4.1M | $3.8M | $2.6M | ||
| Other Assets Noncurrent | $55.0K | $55.0K | $448.0K | $55.0K | $56.0K | $132.0K | ||
| Operating Lease Right Of Use Asset | $535.0K | $808.0K | $1.0M | $1.3M | $1.5M | $936.0K | ||
| Operating Lease Liability Noncurrent | $338.0K | $803.0K | $1.2M | $1.6M | $1.6M | $876.0K | ||
| Operating Lease Liability Current | $465.0K | $414.0K | $368.0K | $326.0K | $288.0K | $124.0K | ||
| Common Stock Value | $1.0K | $0.00 | $4.0K | $4.0K | $4.0K | $3.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.0K | $1.0K | -$349.0K | -$2.0M | -$388.0K | $33.0K | ||
| Accretion Amortization Of Discounts And Premiums Investments | $329.0K | $515.0K | $1.4M | $422.0K | -$493.0K | -$251.0K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $273.0K | $241.0K | $214.0K | $203.0K | $155.0K | |||
| Restricted Cash Noncurrent | $631.0K | $631.0K | $631.0K | $420.0K | ||||
| Long Term Investments | $44.8M | $65.9M | $83.5M | |||||
| Unbilled Grant Receivable Current | $1.2M | $2.3M | $1.3M | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $680.0K | $975.0K | ||||||
| Issuance Of Common Stock Upon Exercise Of Common Stock Options And Vesting Of Restricted Stock Units | $167.0K | $327.0K | ||||||
| Change In Fair Value Of Grant Liability | $464.0K | $100.0K | ||||||
| Issuance Of Common Stock Value During The Period Initial Public Offering Net Of Underwriters Discounts And Commissions | $96.8M | $208.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $26.8M | $32.0M | $37.3M | $57.6M | $83.3M | $106.7M | $154.8M | $185.0M | $211.1M | $262.2M | $280.6M | $302.0M | $336.2M | $350.7M | $363.2M | $259.5M | -$12.5M | -$21.3M | -$18.9M | -$17.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $21.5M | $20.5M | $27.1M | $77.9M | $82.8M | $78.5M | $111.0M | $114.3M | $105.8M | $87.3M | $95.3M | $118.0M | $107.3M | $131.7M | $127.8M | $165.7M | $85.2M | $2.7M | $2.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$22.0M | -$12.8M | $9.4M | $7.5M | $67.2M | $666.0K | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $20.9M | $19.9M | $26.4M | $68.9M | $73.8M | $77.8M | $110.3M | $113.6M | $105.2M | $87.0M | $95.1M | $117.8M | $107.3M | $131.7M | $127.8M | $165.7M | ||||
| Retained Earnings Accumulated Deficit | -$428.9M | -$422.3M | -$415.3M | -$391.1M | -$362.4M | -$335.5M | -$281.9M | -$249.0M | -$219.4M | -$161.4M | -$141.2M | -$116.9M | -$79.6M | -$63.9M | -$49.9M | -$33.3M | ||||
| Prepaid Expense And Other Assets Current | $1.8M | $2.4M | $3.2M | $3.1M | $4.9M | $4.9M | $5.6M | $6.0M | $6.9M | $6.3M | $3.5M | $3.4M | $1.1M | $3.0M | $4.5M | $6.0M | ||||
| Liabilities Current | $2.8M | $3.0M | $5.5M | $27.8M | $26.9M | $25.6M | $28.6M | $21.7M | $20.2M | $10.3M | $9.7M | $9.5M | $9.4M | $7.6M | $4.5M | $7.6M | ||||
| Liabilities And Stockholders Equity | $30.0M | $35.5M | $43.5M | $86.2M | $111.3M | $133.5M | $184.7M | $208.0M | $232.8M | $274.2M | $292.0M | $313.0M | $347.3M | $360.1M | $369.4M | $267.9M | ||||
| Liabilities | $3.2M | $3.6M | $6.2M | $28.7M | $27.9M | $26.7M | $29.9M | $23.1M | $21.6M | $11.9M | $11.4M | $11.0M | $11.1M | $9.4M | $6.2M | $8.5M | ||||
| Assets Current | $27.0M | $32.2M | $39.9M | $82.0M | $106.7M | $128.6M | $178.5M | $192.1M | $192.9M | $229.0M | $255.9M | $269.2M | $239.0M | $290.5M | $311.6M | $232.3M | ||||
| Assets | $30.0M | $35.5M | $43.5M | $86.2M | $111.3M | $133.5M | $184.7M | $208.0M | $232.8M | $274.2M | $292.0M | $313.0M | $347.3M | $360.1M | $369.4M | $267.9M | ||||
| Additional Paid In Capital Common Stock | $455.7M | $454.2M | $452.6M | $448.7M | $445.8M | $442.4M | $437.4M | $434.9M | $431.5M | $426.1M | $423.7M | $420.3M | $415.8M | $414.6M | $413.1M | $292.8M | ||||
| Accrued Liabilities Current | $2.1M | $2.4M | $4.2M | $17.0M | $16.0M | $14.5M | $16.6M | $10.7M | $8.9M | $9.2M | $8.8M | $7.7M | $8.1M | $6.2M | $2.6M | $2.1M | ||||
| Accounts Payable Current | $266.0K | $171.0K | $867.0K | $388.0K | $475.0K | $681.0K | $1.7M | $612.0K | $892.0K | $751.0K | $605.0K | $1.4M | $959.0K | $1.2M | $1.7M | $3.9M | ||||
| Short Term Investments | $4.4M | $9.9M | $10.2M | $17.9M | $44.3M | $62.6M | $72.5M | $80.8M | $133.9M | $157.3M | $145.7M | $128.4M | $153.2M | $176.4M | $60.5M | |||||
| Property Plant And Equipment Net | $1.7M | $2.0M | $2.2M | $2.7M | $2.9M | $3.1M | $3.6M | $3.8M | $4.1M | $4.3M | $4.3M | $4.4M | $3.1M | $2.9M | $2.9M | $1.0M | ||||
| Other Assets Noncurrent | $55.0K | $62.0K | $85.0K | $55.0K | $55.0K | $55.0K | $827.0K | $61.0K | $72.0K | $55.0K | $155.0K | $225.0K | $125.0K | $225.0K | $55.0K | $55.0K | ||||
| Operating Lease Right Of Use Asset | $607.0K | $676.0K | $743.0K | $871.0K | $933.0K | $992.0K | $1.1M | $1.2M | $1.2M | $1.6M | $1.6M | $1.4M | $1.5M | $1.5M | $1.4M | $959.0K | ||||
| Operating Lease Liability Noncurrent | $460.0K | $578.0K | $691.0K | $912.0K | $1.0M | $1.1M | $1.3M | $1.4M | $1.5M | $1.7M | $1.8M | $1.6M | $1.7M | $1.8M | $1.7M | $915.0K | ||||
| Operating Lease Liability Current | $452.0K | $439.0K | $426.0K | $402.0K | $391.0K | $380.0K | $358.0K | $347.0K | $337.0K | $316.0K | $307.0K | $297.0K | $279.0K | $263.0K | $200.0K | $57.0K | ||||
| Common Stock Value | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.0K | -$3.0K | -$4.0K | $3.0K | -$38.0K | -$137.0K | -$678.0K | -$939.0K | -$1.0M | -$2.5M | -$1.9M | -$1.5M | $4.0K | $37.0K | $28.0K | $7.0K | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $65.0K | $266.0K | $331.0K | -$140.0K | -$131.0K | |||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $65.0K | $57.0K | $51.0K | $45.0K | $28.0K | |||||||||||||||
| Restricted Cash Noncurrent | $631.0K | $631.0K | $631.0K | $631.0K | $631.0K | $631.0K | $631.0K | $631.0K | $631.0K | $210.0K | $210.0K | $210.0K | ||||||||
| Long Term Investments | $10.2M | $33.9M | $39.1M | $29.8M | $37.6M | $103.6M | $64.9M | $53.5M | $33.7M | |||||||||||
| Unbilled Grant Receivable Current | $1.7M | $2.2M | $2.1M | $2.6M | $2.9M | |||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $518.0K | |||||||||||||||||||
| Issuance Of Common Stock Upon Exercise Of Common Stock Options And Vesting Of Restricted Stock Units | $83.0K | $130.0K | $70.0K | |||||||||||||||||
| Change In Fair Value Of Grant Liability | $453.0K | -$97.0K | $21.0K | |||||||||||||||||
| Issuance Of Common Stock Value During The Period Initial Public Offering Net Of Underwriters Discounts And Commissions | $96.8M | $186.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $6.1M | $11.0M | $10.6M | $10.6M | $4.6M | $633.0K | $253.0K |
| Net Cash Provided By Used In Operating Activities | -$45.7M | -$97.2M | -$100.8M | -$72.5M | -$43.1M | -$24.1M | -$3.7M |
| Net Cash Provided By Used In Investing Activities | -$15.9M | $54.8M | $95.1M | $57.7M | -$4.1M | -$210.1M | $1.5M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$21.3M | -$5.8M | $7.4M | $2.1M | $5.2M | $2.6M | $701.0K |
| Payments To Acquire Available For Sale Securities Debt | $37.6M | $14.1M | $27.7M | $95.3M | $299.2M | $226.8M | $995.0K |
| Net Cash Provided By Used In Financing Activities | $82.5M | $194.0K | $493.0K | $654.0K | $97.1M | $292.8M | $946.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.4M | -$2.5M | $113.0K | $1.3M | -$1.7M | $6.3M | |
| Increase Decrease In Operating Lease Liability | -$414.0K | -$368.0K | -$326.0K | -$15.0K | $241.0K | $64.0K | |
| Payments To Acquire Property Plant And Equipment | $33.0K | $304.0K | $1.1M | $1.6M | $2.3M | ||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $21.7M | $69.0M | $123.1M | $154.1M | $278.6M | $19.1M | |
| Increase Decrease In Unbilled Grant Receivables | -$1.2M | -$1.1M | $1.0M | $1.3M | |||
| Proceeds From Exercise Of Common Stock Options And Issuance Of Common Stock Under Employee Stock Purchase Plan | $37.0K | $194.0K | $493.0K | $654.0K | |||
| Proceeds From Exercise Of Common Stock Options | $654.0K | $327.0K | |||||
| Proceeds From Sale Of Available For Sale Securities Debt | $18.1M | $19.1M | $2.5M | ||||
| Proceeds From Issuance Initial Public Offering | $96.8M | $208.5M | |||||
| Proceeds From Convertible Debt | $1.7M | $874.0K | |||||
| Proceeds From Collection Of Loans Receivable | $36.0K | $6.0K | |||||
| Proceeds From Exercise Of Common Stock Options And Common Stock Warrants | $327.0K | $643.0K | $72.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.6M | $2.7M | $2.8M | $2.7M | $974.0K | $58.0K |
| Net Cash Provided By Used In Operating Activities | -$14.7M | -$25.8M | -$26.2M | -$16.6M | -$7.3M | -$1.2M |
| Net Cash Provided By Used In Investing Activities | -$7.4M | $13.0M | $35.5M | $23.8M | -$22.7M | $1.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$7.7M | -$3.3M | -$1.3M | $164.0K | -$374.0K | $63.0K |
| Payments To Acquire Available For Sale Securities Debt | $10.2M | $5.9M | $9.7M | $17.8M | $93.1M | |
| Net Cash Provided By Used In Financing Activities | $99.0K | $210.0K | $97.2M | $1.8M | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$353.0K | -$1.2M | $970.0K | -$1.1M | -$1.9M | |
| Increase Decrease In Operating Lease Liability | -$100.0K | -$87.0K | -$77.0K | -$69.0K | $382.0K | |
| Payments To Acquire Property Plant And Equipment | $5.0K | $241.0K | $745.0K | $304.0K | ||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $2.9M | $19.0M | $45.5M | $42.4M | $70.7M | |
| Increase Decrease In Unbilled Grant Receivables | -$1.2M | -$102.0K | $1.6M | |||
| Proceeds From Exercise Of Common Stock Options And Issuance Of Common Stock Under Employee Stock Purchase Plan | $99.0K | |||||
| Proceeds From Exercise Of Common Stock Options | $210.0K | $39.0K | $176.0K | |||
| Proceeds From Sale Of Available For Sale Securities Debt | $70.7M | |||||
| Proceeds From Issuance Initial Public Offering | $97.2M | |||||
| Proceeds From Convertible Debt | $1.7M | |||||
| Proceeds From Collection Of Loans Receivable | $1.0K | |||||
| Proceeds From Exercise Of Common Stock Options And Common Stock Warrants |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$24.70 | -$25.19 | -$3.09 | -$2.53 | -$1.49 | -$1.67 | -$1.45 |
| Common Stock Shares Authorized | 90.0M | 90.0M | 900.0M | 900.0M | 900.0M | 900.0M | 10.1M |
| Common Stock Shares Outstanding | 9.3M | 3.9M | 38.2M | 37.9M | 37.4M | 32.5M | 3.6M |
| Common Stock Shares Issued | 9.3M | 3.9M | 38.2M | 37.9M | 37.4M | 32.5M | 3.6M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 4.3M | 3.8M | 38.0M | 37.7M | 36.9M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 4.3M | 3.8M | 38.0M | 37.7M | 36.9M | ||
| Earnings Per Share Basic | $-24.70 | $-25.19 | $-3.09 | $-2.53 | $-1.49 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 36.9M | 12.0M | 3.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.68 | -$0.18 | -$0.23 | -$7.46 | -$0.70 | -$0.69 | -$0.87 | -$0.78 | -$0.73 | -$0.53 | -$0.65 | -$0.56 | -$0.42 | -$0.38 | -$0.25 | -$1.12 | -$0.48 | -$0.48 | -$0.43 |
| Common Stock Shares Authorized | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | ||||
| Common Stock Shares Outstanding | 3.9M | 39.4M | 39.0M | 38.7M | 38.4M | 38.3M | 38.1M | 38.1M | 38.0M | 37.8M | 37.8M | 37.6M | 37.4M | 37.3M | 37.2M | 31.1M | |||
| Common Stock Shares Issued | 3.9M | 39.4M | 39.0M | 38.7M | 38.4M | 38.3M | 38.1M | 38.1M | 38.0M | 37.8M | 37.8M | 37.6M | 37.4M | 37.3M | 37.2M | 31.1M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 3.9M | 39.1M | 39.0M | 3.9M | 38.4M | 38.3M | 38.1M | 38.0M | 37.9M | 37.8M | 37.7M | 37.6M | 37.3M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.9M | 39.1M | 39.0M | 3.9M | 38.4M | 38.3M | 38.1M | 38.0M | 37.9M | 37.8M | 37.7M | 37.6M | 37.3M | ||||||
| Earnings Per Share Basic | $-1.68 | $-0.18 | $-0.23 | $-7.46 | $-0.70 | $-0.69 | $-0.87 | $-0.78 | $-0.73 | $-0.53 | $-0.65 | $-0.56 | $-0.42 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.7M | 37.6M | 37.3M | 37.2M | 35.8M | 7.6M | 4.1M | 3.7M | 3.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.1M | $11.0M | $10.6M | $10.6M | $4.6M | $633.0K | $253.0K |
| Costs And Expenses | $102.3M | $100.9M | $125.5M | $104.0M | $64.0M | $20.0M | $5.4M |
| Depreciation | $972.0K | $970.0K | $969.0K | $845.0K | $479.0K | $2.0K | |
| Stock Issued During Period Value Stock Options Exercised | $12.0K | $167.0K | $309.0K | $544.0K | $72.0K | ||
| Grant Income | $157.0K | $5.2M | $8.8M | $1.3M | $754.0K | ||
| Stock Issued During Period Value Employee Stock Ownership Plan | $37.0K | $182.0K | $326.0K | $345.0K | $364.0K | ||
| Loss Contingency Accrual Carrying Value Current | $10.0M | $10.0M | |||||
| Stock Issued During Period Shares Stock Options Exercised | 75.7K | 128.5K | 300.0K | 263.5K | 540.9K | ||
| Litigation Settlement Expense | $4.1M | $10.0M | |||||
| Capital Expenditures Incurred But Not Yet Paid | $14.0K | $331.0K | |||||
| Stock Issued During Period Value Warrants Exercised | $1.1M | ||||||
| Accretion Expense | $289.0K | $258.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $1.6M | $1.6M | $2.9M | $3.2M | $2.7M | $2.5M | $3.1M | $2.8M | $2.4M | $3.1M | $2.7M | $1.1M | $1.1M | $974.0K | $111.0K | $49.0K | $58.0K | $69.0K | ||
| Costs And Expenses | $6.9M | $7.3M | $9.5M | $29.6M | $28.0M | $27.7M | $35.0M | $31.6M | $29.8M | $24.1M | $23.6M | $23.4M | $17.8M | $16.6M | $10.8M | $7.4M | $2.3M | $1.3M | $1.5M | ||
| Depreciation | $200.0K | $200.0K | $243.0K | $200.0K | $200.0K | $242.0K | $244.0K | $244.0K | $236.0K | $231.0K | $221.0K | $154.0K | $123.0K | $118.0K | $112.0K | $0.00 | $0.00 | $0.00 | |||
| Stock Issued During Period Value Stock Options Exercised | $12.0K | $11.0K | $99.0K | $83.0K | $210.0K | $119.0K | $304.0K | $62.0K | $176.0K | $6.0K | |||||||||||
| Grant Income | $157.0K | $3.0M | -$1.3M | $2.2M | $2.1M | $2.6M | $1.8M | $22.0K | |||||||||||||
| Stock Issued During Period Value Employee Stock Ownership Plan | $24.0K | $148.0K | $231.0K | $214.0K | $229.0K | ||||||||||||||||
| Loss Contingency Accrual Carrying Value Current | $10.0M | $10.0M | $10.0M | $10.0M | $10.0M | $10.0M | |||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 73.2K | 245.0K | 63.0K | ||||||||||||||||||
| Litigation Settlement Expense | $4.1M | $4.1M | $10.0M | ||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $6.0K | $57.0K | |||||||||||||||||||
| Stock Issued During Period Value Warrants Exercised | $1.1M | $55.0K | |||||||||||||||||||
| Accretion Expense | $172.0K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.